Yüklüyor......
Novel opportunities for CFTR-targeting drug development using organoids
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR mutations lead to production of non-functional CFTR, reduced amounts of normal functioning CFTR or misfolded CFTR with defects in trafficking or function. For decades, CF treatmen...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3915567/ https://ncbi.nlm.nih.gov/pubmed/25003014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/rdis.27112 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|